News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
391,656 Results
Type
Article (24417)
Company Profile (298)
Press Release (366941)
Multimedia
Podcasts (56)
Webinars (9)
Section
Business (112639)
Career Advice (716)
Deals (20417)
Drug Delivery (59)
Drug Development (63070)
Employer Resources (88)
FDA (8929)
Job Trends (7857)
News (203144)
Policy (16047)
Tag
Academia (1686)
Academic (1)
Accelerated approval (3)
Adcomms (16)
Allergies (69)
Alliances (30699)
ALS (78)
Alzheimer's disease (1060)
Antibody-drug conjugate (ADC) (110)
Approvals (8950)
Artificial intelligence (164)
Autoimmune disease (22)
Automation (6)
Bankruptcy (162)
Best Places to Work (6576)
BIOSECURE Act (10)
Biosimilars (58)
Biotechnology (238)
Bladder cancer (66)
Brain cancer (24)
Breast cancer (199)
Cancer (1746)
Cardiovascular disease (147)
Career advice (603)
Career pathing (13)
CAR-T (128)
Cell therapy (357)
Cervical cancer (14)
Clinical research (51711)
Collaboration (637)
Compensation (281)
Complete response letters (15)
COVID-19 (1723)
CRISPR (42)
C-suite (189)
Cystic fibrosis (83)
Data (1832)
Denatured (17)
Depression (41)
Diabetes (209)
Diagnostics (2690)
Digital health (6)
Diversity (5)
Diversity, equity & inclusion (31)
Drug discovery (97)
Drug pricing (62)
Drug shortages (18)
Duchenne muscular dystrophy (94)
Earnings (40495)
Editorial (28)
Employer branding (9)
Employer resources (81)
Events (63104)
Executive appointments (569)
FDA (9803)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (575)
Gene editing (100)
Generative AI (13)
Gene therapy (277)
GLP-1 (587)
Government (1956)
Grass and pollen (4)
Guidances (33)
Healthcare (10638)
Huntington's disease (22)
IgA nephropathy (28)
Immunology and inflammation (104)
Indications (24)
Infectious disease (1821)
Inflammatory bowel disease (127)
Inflation Reduction Act (10)
Influenza (32)
Intellectual property (76)
Interviews (117)
IPO (9610)
IRA (27)
Job creations (1615)
Job search strategy (536)
Kidney cancer (8)
Labor market (11)
Layoffs (264)
Leadership (10)
Legal (2989)
Liver cancer (45)
Lung cancer (232)
Lymphoma (115)
Machine learning (4)
Management (26)
Manufacturing (187)
MASH (62)
Medical device (5339)
Medtech (5342)
Mergers & acquisitions (11206)
Metabolic disorders (544)
Multiple sclerosis (67)
NASH (17)
Neurodegenerative disease (77)
Neuropsychiatric disorders (27)
Neuroscience (1534)
NextGen: Class of 2025 (3519)
Non-profit (2196)
Now hiring (22)
Obesity (282)
Opinion (138)
Ovarian cancer (67)
Pain (65)
Pancreatic cancer (65)
Parkinson's disease (132)
Partnered (12)
Patents (152)
Patient recruitment (93)
Peanut (40)
People (36415)
Pharmaceutical (54)
Pharmacy benefit managers (11)
Phase I (16423)
Phase II (23171)
Phase III (16787)
Pipeline (941)
Policy (85)
Postmarket research (1678)
Preclinical (6897)
Press Release (61)
Prostate cancer (83)
Psychedelics (37)
Radiopharmaceuticals (225)
Rare diseases (324)
Real estate (2603)
Recruiting (33)
Regulatory (12528)
Reports (20)
Research institute (1535)
Resumes & cover letters (94)
Rett syndrome (4)
RNA editing (5)
RSV (27)
Schizophrenia (67)
Series A (109)
Series B (71)
Service/supplier (3)
Sickle cell disease (42)
Special edition (12)
Spinal muscular atrophy (132)
Sponsored (14)
Startups (2566)
State (1)
Stomach cancer (6)
Supply chain (36)
Tariffs (17)
The Weekly (38)
Vaccines (440)
Venture capitalists (34)
Weight loss (171)
Women's health (26)
Worklife (8)
Date
Today (136)
Last 7 days (625)
Last 30 days (1822)
Last 365 days (23466)
2025 (7539)
2024 (24847)
2023 (27543)
2022 (34699)
2021 (36632)
2020 (32622)
2019 (26046)
2018 (19485)
2017 (20124)
2016 (18425)
2015 (22253)
2014 (16170)
2013 (12181)
2012 (12613)
2011 (12909)
2010 (11925)
Location
Africa (352)
Alabama (44)
Alaska (4)
Arizona (83)
Arkansas (7)
Asia (25173)
Australia (4386)
California (4335)
Canada (1341)
China (414)
Colorado (175)
Connecticut (177)
Delaware (117)
Europe (64148)
Florida (559)
Georgia (164)
Idaho (30)
Illinois (331)
India (17)
Indiana (171)
Iowa (5)
Japan (117)
Kansas (70)
Kentucky (12)
Louisiana (8)
Maine (19)
Maryland (596)
Massachusetts (3421)
Michigan (99)
Minnesota (201)
Mississippi (1)
Missouri (42)
Montana (17)
Nebraska (10)
Nevada (31)
New Hampshire (21)
New Jersey (1196)
New Mexico (17)
New York (1259)
North Carolina (668)
North Dakota (5)
Northern California (1912)
Ohio (133)
Oklahoma (12)
Oregon (25)
Pennsylvania (873)
Puerto Rico (8)
Rhode Island (21)
South America (532)
South Carolina (11)
Southern California (1666)
Tennessee (38)
Texas (562)
United States (15713)
Utah (67)
Virginia (103)
Washington D.C. (35)
Washington State (418)
Wisconsin (23)
391,656 Results for "peptide therapeutics group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M
Merck has not disclosed which of its peptide therapies it plans to develop oral formulations for.
April 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
April 15, 2025
·
2 min read
Press Releases
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
April 30, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Final Results
April 29, 2025
·
1 min read
Press Releases
Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery
April 23, 2025
·
6 min read
Press Releases
Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
May 1, 2025
·
3 min read
Press Releases
Cybrexa Therapeutics Announces New Preclinical Data on Tumor-Selective Peptide-Drug Conjugates at ESMO Targeted Anticancer Therapies Congress 2025
March 4, 2025
·
4 min read
Press Releases
CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations
March 11, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
May 2, 2025
·
3 min read
Press Releases
Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc
February 27, 2025
·
13 min read
1 of 39,166
Next
